Abstract 3707: Characterization of estrogen receptor expression on CTCs during CDK4/6i treatment in HR+/HER2- metastatic breast cancer: Results from the PACE phase II study
Recommended Citation
Serafini MS, Reduzzi C, Gerratana L, et al. Abstract 3707: Characterization of estrogen receptor expression on CTCs during CDK4/6i treatment in HR+/HER2- metastatic breast cancer: Results from the PACE phase II study. Cancer Research. 2024;84(6_Supplement):3707-3707. doi:10.1158/1538-7445.Am2024-3707
Type
Abstract
